Correlation Between Edgewise Therapeutics and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Oramed Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Oramed Pharmaceuticals
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Oramed is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Oramed Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.62 times more return on investment than Oramed Pharmaceuticals. However, Edgewise Therapeutics is 1.62 times more volatile than Oramed Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest 640.00 in Edgewise Therapeutics on August 26, 2024 and sell it today you would earn a total of 2,580 from holding Edgewise Therapeutics or generate 403.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Oramed Pharmaceuticals |
Edgewise Therapeutics and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Oramed Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Oramed Pharmaceuticals vs. Capricor Therapeutics | Oramed Pharmaceuticals vs. Akari Therapeutics PLC | Oramed Pharmaceuticals vs. Soleno Therapeutics | Oramed Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |